You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Leukemia, Myeloid, Acute

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Leukemia, Myeloid, Acute Trial in Guanzhou (Azacitidine, Venetoclax)

Not yet recruiting
  • Leukemia, Myeloid, Acute
  • Guanzhou, Guandong, China
    Nanfang Hospital of Southern Medical University
Jul 22, 2022

Leukemia, Myeloid, Acute Trial in Baltimore (Flotetuzumab)

Not yet recruiting
  • Leukemia, Myeloid, Acute
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Aug 16, 2022

Acute Myeloid Leukemia Patients on Correlation to CD200 and CD56

Not yet recruiting
  • Acute Myeloid Leukemia
  • bone marrow aspirate and biopsy
  • (no location specified)
Aug 20, 2022

Novel Digital Array PCR for Acute Myeloid Leukemia (AML)

Recruiting
  • Leukemia, Myeloid, Acute
  • Minimal Residual Disease
    • Chapel Hill, North Carolina
      North Carolina Cancer Hospital (NCCH)
    Jun 10, 2022

    Acute Myeloid Leukemia Trial (CIML-NK Cells)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • CIML-NK Cells
    • (no location specified)
    Oct 12, 2022

    Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse Trial in Xuzhou (anti-siglec-6 CAR-T cell therapy)

    Recruiting
    • Acute Myeloid Leukemia Refractory
    • Acute Myeloid Leukemia, in Relapse
    • anti-siglec-6 CAR-T cell therapy
    • Xuzhou, Jiangsu, China
      Kailin Xu
    Aug 2, 2022

    Acute Myeloid Leukemia (AML) Trial in Charlotte (Allogeneic HCT, Consolidation chemo)

    Terminated
    Has Results
    • Acute Myeloid Leukemia (AML)
    • Allogeneic HCT
    • Consolidation chemotherapy
    • Charlotte, North Carolina
      Levine Cancer Institute
    Apr 19, 2022

    Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia Recurrent Trial (CD123-CAR-NK cells)

    Not yet recruiting
    • Acute Myeloid Leukemia Refractory
    • Acute Myeloid Leukemia Recurrent
    • CD123-CAR-NK cells
    • (no location specified)
    Oct 7, 2022

    Acute Myeloid Leukemia Trial in Houston (SNDX-5613)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Houston, Texas
      MD Anderson Cancer Center
    Jul 27, 2022

    Relapsed or Refractory Acute Myeloid Leukemia (AML) Trial (Mitoxantrone Hydrochloride Liposome)

    Not yet recruiting
    • Relapsed or Refractory Acute Myeloid Leukemia (AML)
    • Mitoxantrone Hydrochloride Liposome
    • (no location specified)
    Apr 19, 2022

    Analyze Occurrence of Transformation From Myelodysplastic

    Completed
    • Myelodysplastic Syndromes
    • Leukemia, Myeloid, Acute
      • Kobe, Hyogo, Japan
        Shinko Hospital
      Jun 13, 2022

      Acute Myeloid Leukemia Trial (with or without venetoclax)

      Not yet recruiting
      • Acute Myeloid Leukemia
      • with or without venetoclax
      • (no location specified)
      Apr 29, 2022

      Leukemia, Myeloid, Acute Trial in Poznan (Liposomal Annamycin, Cytarabine)

      Not yet recruiting
      • Leukemia, Myeloid, Acute
      • Poznań, Poland
        Szpital Kliniczny Przemienienia Pańskiego Uniwersytetu Medyczneg
      Jun 30, 2022

      Acute Myeloid Leukemia Trial in Xi'an (infusion of natural killer cells)

      Recruiting
      • Acute Myeloid Leukemia
      • infusion of natural killer cells
      • Xi'an, Shaanxi, China
        First Affiliated Hospital of Xian Jiaotong University
      Apr 17, 2022

      Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia, Acute Myeloid Leukemia, in Relapse Trial in Miami (Bomedemstat,

      Not yet recruiting
      • Acute Myeloid Leukemia
      • +2 more
      • Miami, Florida
        University of Miami
      Oct 24, 2022

      AML, Acute Myeloid Leukemia Trial in Boston (DREAMLAND, CERENA)

      Not yet recruiting
      • AML
      • Acute Myeloid Leukemia
      • DREAMLAND
      • CERENA
      • Boston, Massachusetts
        Massachusetts General Hospital
      Aug 12, 2022

      Acute Myeloid Leukemia Trial in Aurora (Azacitidine, Venetoclax)

      Recruiting
      • Acute Myeloid Leukemia
      • Aurora, Colorado
        Universtiy of Colorado Hospital
      Feb 15, 2022

      Acute Myeloid Leukemia, Relapsed, Adult Trial in Suzhou (CDIAG regimen)

      Completed
      • Acute Myeloid Leukemia, Relapsed, Adult
      • CDIAG regimen
      • Suzhou, Jiangsu, China
        The First Affliated Hospital of Soochow University
      Mar 16, 2022

      Relapsed/Refractory Acute Myeloid Leukemia Trial (LILRB4 STAR-T cells)

      Not yet recruiting
      • Relapsed/Refractory Acute Myeloid Leukemia
      • LILRB4 STAR-T cells
      • (no location specified)
      Sep 16, 2022

      Venetoclax in Patients With Acute Myeloid Leukemia

      Recruiting
      • Acute Myeloid Leukemia
      • Taipei, Taiwan
        National Taiwan University Hospital
      Oct 27, 2021

      Leukemia, Myeloid, Acute Trial in Chongqing (anti-CD33 CAR NK cells, Fludarabine, Cytoxan)

      Recruiting
      • Leukemia, Myeloid, Acute
      • anti-CD33 CAR NK cells
      • +2 more
      • Chongqing, Chongqing, China
        Department of Hematology, Xinqiao Hospital
      Dec 22, 2021

      Healthcare Resource Utilization in Adults Diagnosed With Acute

      Completed
      • Acute Myeloid Leukemia (AML)
      • Helsinki, Finland
        Novartis Investigative Site
      Aug 3, 2022

      Acute Myeloid Leukemia Trial in Wuhan (Fludarabine + Cyclophosphamide + TAA05 Cell Injection)

      Recruiting
      • Acute Myeloid Leukemia
      • Fludarabine + Cyclophosphamide + TAA05 Cell Injection
      • Wuhan, Hubei, China
        Wuhan Union Hospital
      Jun 29, 2022

      Malnutrition And Sarcopenia In Older Acute Myeloid Leukemia

      Not yet recruiting
      • Acute Myeloid Leukemia
      • Leukemia, Myeloid
      • Bioelectrical Impedence Analysis Device
      • +4 more
      • (no location specified)
      Jul 11, 2022

      Acute Myeloid Leukemia Trial in Gainesville (Integrative Therapy)

      Suspended
      • Acute Myeloid Leukemia
      • Integrative Therapy
      • Gainesville, Florida
        University of Florida
      Jan 14, 2022